CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 97 enrolled
Drug / intervention
Oxycodonedrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01959204
NCT01959204Phase 4Completed
CompareCT.gov

A Phase IV Study to Evaluate the Pharmacokinetics and Safety of Oxycodone Oral Solution in Pediatric and Adolescent Subjects

VistaPharm, Inc.·interventional·Posted Oct 9, 2013·Updated Jan 11, 2023

In Brief

A Phase 4 clinical trial evaluating Oxycodone for Pain. Completed, enrolled 97 participants across 9 sites.

Detailed Summary

The objective of this study is to characterize the pharmacokinetics and to evaluate the safety of single and multiple doses of Oxycodone Oral Solution in pediatric and adolescent subjects for postoperative pain.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPain
CountriesUnited States
Collaborators--

Timeline

Phase 4CompletedFinished
2014201520162017201820192020202120222023202420252026
First PostedOct 9, 2013
Enrollment StartOct 14, 2013
Primary CompletionAug 21, 2019
TodayJul 2, 2026
Enrollment to primary: 5.9 yearsPosted 12.7 years ago

Interventions

Oxycodonedrug

Pain